Answers are grounded in this paper and cite their sources.
Pathological axillary lymph node (pALN) burden is an important factor for treatment decision-making in clinical T1-T2 (cT1-T2) stage breast cancer. Preoperative assessment of the pALN burden and prognosis aids in the individualized selection of therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: